EUVIMEDEUVIMED entdecken
Open Access

Considerations of Sex and Gender in FDA Tobacco Regulation

Danielle R Davis, Suchitra Krishnan-Sarin, Carolyn M Mazure

JAMA · 2023

DOI: 10.1001/jama.2023.6803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Danielle R Davis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Tobacco Control, Tobacco Industry, Tobacco Products. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Viewpoint discusses how sex and gender subpopulations may be differentially affected by tobacco products and suggests that the FDA formulate regulations in clinically meaningful ways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tobacco ControlTobacco IndustryTobacco ProductsFemaleHumansMaleGovernment RegulationUnited StatesUnited States Food and Drug AdministrationSex FactorsGender Identity

Autor:innen und Institutionen

  • Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
  • Department of Psychology, Yale School of Medicine, New Haven, Connecticut.

Förderung

  • NIDA NIH HHS

Zitieren

APA

Davis, D. R., Krishnan-Sarin, S., & Mazure, C. M. (2023). Considerations of Sex and Gender in FDA Tobacco Regulation. JAMA. https://doi.org/10.1001/jama.2023.6803

Vancouver

Davis DR, Krishnan-Sarin S, Mazure CM. Considerations of Sex and Gender in FDA Tobacco Regulation. JAMA. 2023. doi:10.1001/jama.2023.6803

BibTeX
@article{Davis2023,
  author = {Davis, Danielle R and Krishnan-Sarin, Suchitra and Mazure, Carolyn M},
  title = {Considerations of Sex and Gender in FDA Tobacco Regulation},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.6803}
}
Kostenlos starten →